VANCOUVER, BRITISH COLUMBIA--(Marketwired - Apr 30, 2013) - Carrus Capital Corporation (TSX VENTURE:CHQ) (the "Company"), would like to welcome Gordon Medland, who has been appointed to the Company's board of directors and Audit Committee.
The Company also announces that, in accordance with the Company's stock option plan, it will grant stock options to certain directors to purchase up to 200,000 common shares exercisable at $0.11, which have a five year term and vest over a year. The Company has also cancelled 80,700 stock options, which were exercisable at a price of $1.10 per share, with expiry dates from October 30, 2013 to October 30, 2014.
The issuance of stock options and the board appointment are subject to exchange approval.
About Carrus Capital Corporation
Carrus Capital Corporation's primary business is the identification of and strategic investment in securities of publicly listed corporations offering capital appreciation potential. Investments will be acquired and held for both short-term gains and long-term capital appreciation, dependent upon the specific investment.